text
"['\n4. 매출 및 수주상황\n가. 매출실적\n\xa0 \xa0 \xa0 ( 단위 : 백만원 )\n구분\n사업부문\n품목\n구분\n제53 기 1분기\n제52 기\n제51 기\n계속영업사업\n산업설비공사\n산업설비플랜트E.P.C\n수출\n-\n84\n1,181\n내수\n28,202\n120,255\n70,505\n합계\n28,202\n120,339\n71,686\n화장품\n노보스트라타 등\n수출\n-\n-\n-\n내수\n-\n351\n402\n합계\n-\n351\n402\n건강식품\n스위치온 등\n수출\n-\n-\n-\n내수\n255\n2,371\n1,253\n합계\n255\n2,371\n1,253\n셀론텍\n리젠씰, 카티졸 등\n수출\n-\n-\n-\n내수\n3,485\n14,150\n2,345\n합계\n3,485\n14,150\n2,345\n기타\n젠바디 등\n수출\n-\n-\n-\n내수\n-\n13\n39\n합계\n-\n13\n39\n소계\n수출\n-\n84\n1,181\n내수\n31,942\n137,140\n74,544\n합계\n31,942\n137,224\n75,725\n중단영업사업\n세원이앤씨_PE\n열교환기,반응기 등\n수출\n-\n-\n-\n내수\n-\n-\n-\n합계\n-\n-\n-\n세원이앤씨_PL\nVALVE 등\n수출\n-\n-\n-\n내수\n-\n-\n-\n합계\n-\n-\n-\n세원이앤씨_RMS\n세포치료제,가족제대혈은행\n수출\n-\n-\n-\n내수\n-\n-\n-\n합계\n-\n-\n-\n상해세원액압유한공사\nVALVE 등\n수출\n-\n-\n-\n내수\n-\n-\n-\n합계\n-\n-\n-\n셀론텍\n콘드론, 오스론,베이비셀\n수출\n-\n-\n-\n내수\n-\n-\n147\n합계\n-\n-\n147\n소계\n수출\n-\n-\n-\n내수\n-\n-\n147\n합계\n-\n-\n147\n나. 수주상황\n\xa0 \xa0 \xa0 ( 단위 : 천원 )\n구분\n기초\n증감액\n공사수익인식\n기말\n산업설비공사\n106,879,662\n7,000,000\n28,694,677\n85,184,986\n다. 진행률 적용 수주 현황\n(단위: 천원)\n계약처\n계약일자\n계약상완성기한\n진행률\n수주총액\n계약자산\n매출채권\n총액\n손상차손누계액\n총액\n대손충당금\n금호미쓰이화학㈜\n21/06/29\n23/04/30\n95%\n30,398,600\n1,513,628\n-\n790,020\n-\n티이엠씨 주식회사\n21/11/16\n22/11/30\n100%\n7,066,900\n108,000\n-\n-\n-\n금호석유화학(주)여수정밀화학\n21/12/17\n23/06/30\n73%\n22,440,000\n-\n-\n1,246,300\n-\n에스케이 트리켐 주식회사\n22/03/21\n23/02/15\n94%\n29,967,000\n2,221,573\n-\n-\n-\n에어리퀴드어드밴스드머티리얼즈\n22/06/07\n23/11/20\n31%\n62,600,000\n-\n-\n8,211,500\n-\n금호석유화학(주)여수정밀화학\n22/12/16\n23/07/31\n47%\n7,395,000\n135,848\n-\n1,115,180\n-\n에스케이머티리얼즈그룹포틴\n23/01/25\n24/02/24\n6%\n7,000,000\n-\n-\n-\n-\n']"
